• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫腺肌病及其潜在恶性变:文献综述

Adenomyosis and Its Possible Malignancy: A Review of the Literature.

作者信息

Moraru Liviu, Mitranovici Melinda-Ildiko, Chiorean Diana Maria, Moraru Raluca, Caravia Laura, Tiron Andreea Taisia, Cotoi Ovidiu Simion

机构信息

Department of Anatomy, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology, 540142 Targu Mures, Romania.

Department of Obstetrics and Gynecology, Emergency County Hospital Hunedoara, 14 Victoriei Street, 331057 Hunedoara, Romania.

出版信息

Diagnostics (Basel). 2023 May 28;13(11):1883. doi: 10.3390/diagnostics13111883.

DOI:10.3390/diagnostics13111883
PMID:37296736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10252751/
Abstract

Cancer arising from adenomyosis is very rare, with transformation occurring in only 1% of cases and in older individuals. Adenomyosis, endometriosis and cancers may share a common pathogenic mechanism that includes hormonal factors, genetic predisposition, growth factors, inflammation, immune system dysregulation, environmental factors and oxidative stress. Endometriosis and adenomyosis both exhibit malignant behaviour. The most common risk factor for malignant transformation is prolonged exposure to oestrogens. The golden standard for diagnosis is histopathology. Colman and Rosenthal emphasised the most important characteristics in adenomyosis-associated cancer. Kumar and Anderson emphasised the importance of demonstrating a transition between benign and malignant endometrial glands in cancer arising from adenomyosis. As it is very rare, it is difficult to standardize treatment. In this manuscript, we try to emphasize some aspects regarding the management strategy, as well as how heterogenous the studies from the literature are in terms of prognosis in both cancers that develop from adenomyosis or those that are only associated with adenomyosis. The pathogenic mechanisms of transformation remain unclear. As these types of cancer are so rare, there is no standardised treatment. A novel target in the diagnosis and treatment of gynaecological malignancies associated with adenomyosis is also being studied for the development of new therapeutic concepts.

摘要

子宫腺肌病相关癌症非常罕见,仅1%的病例会发生恶变,且多发生于老年个体。子宫腺肌病、子宫内膜异位症和癌症可能具有共同的致病机制,包括激素因素、遗传易感性、生长因子、炎症、免疫系统失调、环境因素和氧化应激。子宫内膜异位症和子宫腺肌病都具有恶性行为。恶变的最常见危险因素是长期暴露于雌激素。诊断的金标准是组织病理学。科尔曼和罗森塔尔强调了子宫腺肌病相关癌症的最重要特征。库马尔和安德森强调了在子宫腺肌病相关癌症中显示良性和恶性子宫内膜腺体之间过渡的重要性。由于其非常罕见,难以标准化治疗。在本手稿中,我们试图强调管理策略的一些方面,以及文献中关于子宫腺肌病相关癌症或仅与子宫腺肌病相关癌症预后的研究差异有多大。恶变的致病机制仍不清楚。由于这类癌症非常罕见,尚无标准化治疗方法。与子宫腺肌病相关的妇科恶性肿瘤诊断和治疗的新靶点也在研究中,以开发新的治疗理念。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10252751/a61ecfd3f8b8/diagnostics-13-01883-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10252751/a61ecfd3f8b8/diagnostics-13-01883-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10252751/a61ecfd3f8b8/diagnostics-13-01883-g001.jpg

相似文献

1
Adenomyosis and Its Possible Malignancy: A Review of the Literature.子宫腺肌病及其潜在恶性变:文献综述
Diagnostics (Basel). 2023 May 28;13(11):1883. doi: 10.3390/diagnostics13111883.
2
Endometriosis, leiomyoma and adenomyosis: the risk of gynecologic malignancy.子宫内膜异位症、平滑肌瘤和子宫腺肌病:妇科恶性肿瘤的风险。
Asian Pac J Cancer Prev. 2013;14(10):5589-97. doi: 10.7314/apjcp.2013.14.10.5589.
3
Malignant transformation of adenomyosis: literature review and meta-analysis.子宫腺肌病的恶性转化:文献复习和荟萃分析。
Arch Gynecol Obstet. 2019 Jan;299(1):47-53. doi: 10.1007/s00404-018-4991-2. Epub 2018 Dec 5.
4
Women with adenomyosis are at higher risks of endometrial and thyroid cancers: A population-based historical cohort study.患有子宫腺肌病的女性患子宫内膜癌和甲状腺癌的风险更高:基于人群的历史队列研究。
PLoS One. 2018 Mar 9;13(3):e0194011. doi: 10.1371/journal.pone.0194011. eCollection 2018.
5
Immunological changes associated with adenomyosis: a systematic review.与子宫腺肌病相关的免疫学变化:系统评价。
Hum Reprod Update. 2021 Jan 4;27(1):108-129. doi: 10.1093/humupd/dmaa038.
6
Adenomyosis pathogenesis: insights from next-generation sequencing.子宫腺肌病发病机制的研究进展:下一代测序技术的启示。
Hum Reprod Update. 2021 Oct 18;27(6):1086-1097. doi: 10.1093/humupd/dmab017.
7
Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review.子宫内膜异位症、子宫腺肌病和子宫内膜癌的共同致病及治疗特征:一项全面的文献综述
Pharmaceuticals (Basel). 2024 Feb 28;17(3):311. doi: 10.3390/ph17030311.
8
TIPE2 inhibits the migration and invasion of endometrial cells by targeting β-catenin to reverse epithelial-mesenchymal transition.TIPE2 通过靶向β-catenin 抑制子宫内膜细胞的迁移和侵袭,从而逆转上皮-间充质转化。
Hum Reprod. 2020 Jun 1;35(6):1377-1390. doi: 10.1093/humrep/deaa062.
9
The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.新诊断为子宫内膜异位症或子宫腺肌病的女性患卵巢癌、子宫内膜癌、乳腺癌、结直肠癌及其他癌症的风险:一项基于人群的研究。
Int J Gynecol Cancer. 2015 Jul;25(6):968-76. doi: 10.1097/IGC.0000000000000454.
10
Endometrial Serous Carcinoma Arising From Adenomyosis: A Clinico-Pathological Insight.源自子宫腺肌病的子宫内膜浆液性癌:临床病理观察
J Family Reprod Health. 2021 Jun;15(2):125-129. doi: 10.18502/jfrh.v15i2.6454.

引用本文的文献

1
Analysis and validation of novel biomarkers related to palmitoylation in adenomyosis.子宫腺肌病中与棕榈酰化相关的新型生物标志物的分析与验证
Front Genet. 2025 Aug 4;16:1614573. doi: 10.3389/fgene.2025.1614573. eCollection 2025.
2
Evaluating the Cost-Effectiveness of Cervical Cancer Screening and Treatment in Western Romania.评估罗马尼亚西部宫颈癌筛查与治疗的成本效益
Curr Oncol. 2025 Jun 7;32(6):336. doi: 10.3390/curroncol32060336.
3
Endometriosis: An Immunologist's Perspective.子宫内膜异位症:免疫学家的观点。

本文引用的文献

1
Endometrioid adenocarcinoma arising in adenomyosis in a patient with pelvic organ prolapse-case report.在患有盆腔器官脱垂的患者中,源自于子宫腺肌病的子宫内膜样腺癌病例报告。
BMC Womens Health. 2023 Mar 30;23(1):150. doi: 10.1186/s12905-023-02310-6.
2
Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.腺肌病作为子宫肌层或子宫内膜肿瘤的风险因素-综述。
Int J Environ Res Public Health. 2022 Feb 17;19(4):2294. doi: 10.3390/ijerph19042294.
3
Endometriosis and gynaecological cancers: molecular insights behind a complex machinery.
Int J Mol Sci. 2025 May 28;26(11):5193. doi: 10.3390/ijms26115193.
4
Uterine Artery Embolization as an Alternative Therapeutic Option in Adenomyosis: An Observational Retrospective Single-Center Study.子宫动脉栓塞术作为子宫腺肌病的一种替代治疗选择:一项观察性回顾性单中心研究。
J Clin Med. 2025 May 28;14(11):3788. doi: 10.3390/jcm14113788.
5
Adenomyosis and endometrial cancer: determining its role as a biological contributor or incidental coexistence.子宫腺肌病与子宫内膜癌:确定其作为生物学促成因素或偶然并存情况的作用。
BMC Cancer. 2025 Jun 2;25(1):984. doi: 10.1186/s12885-025-14389-1.
6
Circular RNAs in endometriosis analyzed through RNA sequencing and bioinformatics for expression profile.通过RNA测序和生物信息学分析子宫内膜异位症中的环状RNA以获取表达谱。
PeerJ. 2025 Apr 16;13:e19298. doi: 10.7717/peerj.19298. eCollection 2025.
7
Adenomyosis as a prognostic factor in ovarian cancer: a retrospective study.子宫腺肌病作为卵巢癌的预后因素:一项回顾性研究。
Arch Gynecol Obstet. 2025 Apr 16. doi: 10.1007/s00404-025-08023-5.
8
Birth Outcomes in Pregnancies with Uterine Malformations: A Single-Center Retrospective Study.子宫畸形妊娠的分娩结局:一项单中心回顾性研究。
J Clin Med. 2025 Mar 30;14(7):2379. doi: 10.3390/jcm14072379.
9
Retrospective study of the factors involved in the development of adenomyosis and the link between adenomyosis and breast cancer.子宫腺肌病发生相关因素及子宫腺肌病与乳腺癌之间联系的回顾性研究。
Med Pharm Rep. 2024 Oct;97(4):477-487. doi: 10.15386/mpr-2747. Epub 2024 Oct 30.
10
Artificial Intelligence Algorithms in Predictive Factors for Hematologic Toxicities During Concurrent Chemoradiation for Cervical Cancer.人工智能算法在宫颈癌同步放化疗期间血液学毒性预测因素中的应用
Cureus. 2024 Oct 1;16(10):e70665. doi: 10.7759/cureus.70665. eCollection 2024 Oct.
子宫内膜异位症与妇科癌症:复杂机制背后的分子见解
Prz Menopauzalny. 2021 Dec;20(4):201-206. doi: 10.5114/pm.2021.111276. Epub 2021 Dec 6.
4
Primary low-grade extrauterine endometrial stromal sarcoma: analysis of 10 cases with a review of the literature.原发性低级别子宫外内膜基质肉瘤:10 例分析并文献复习。
World J Surg Oncol. 2022 Jan 13;20(1):17. doi: 10.1186/s12957-021-02474-1.
5
Ectopic Endometrium: The Pathologist's Perspective.异位子宫内膜:病理学家的视角。
Int J Mol Sci. 2021 Oct 11;22(20):10974. doi: 10.3390/ijms222010974.
6
Endometrial Cancer Incidence in Endometriosis and Adenomyosis.子宫内膜异位症和子宫腺肌病中的子宫内膜癌发病率
Cancers (Basel). 2021 Sep 13;13(18):4592. doi: 10.3390/cancers13184592.
7
Molecular Basis of Endometriosis and Endometrial Cancer: Current Knowledge and Future Perspectives.子宫内膜异位症和子宫内膜癌的分子基础:当前知识和未来展望。
Int J Mol Sci. 2021 Aug 27;22(17):9274. doi: 10.3390/ijms22179274.
8
Malignant Transformation of Postmenopausal Endometriosis: A Systematic Review of the Literature.绝经后子宫内膜异位症的恶性转化:文献系统评价
Cancers (Basel). 2021 Aug 10;13(16):4026. doi: 10.3390/cancers13164026.
9
IL-37bΔ1-45 suppresses the migration and invasion of endometrial cancer cells by targeting the Rac1/NF-κB/MMP2 signal pathway.IL-37bΔ1-45 通过靶向 Rac1/NF-κB/MMP2 信号通路抑制子宫内膜癌细胞的迁移和侵袭。
Lab Invest. 2021 Jun;101(6):760-774. doi: 10.1038/s41374-021-00544-2. Epub 2021 Mar 22.
10
Carcinosarcoma of the Uterus: A Study From the Surveillance Epidemiology and End Result (SEER) Database.子宫癌肉瘤:来自监测、流行病学和最终结果(SEER)数据库的一项研究
Cureus. 2020 Sep 6;12(9):e10283. doi: 10.7759/cureus.10283.